value. quality care. convenience.
A Mobile Platform for Physicians, Hospitals and Insurance Firms
mHealth
mobile diagnosis technology
EARLY DIAGNOSIS
biochip development is progressing to the preparation of an integrated device in which basic processes necessary for genomic/proteome analysis, such as DNA, RNA and protein extractions from cells, reactions including enzymatic digestion, PCR, loop-mediated isothermal amplification, electrophoresis, hybridization, detection of laser-induced fluorescence and electrochemical detection, are integrated on a few centimeter-squared microchips.
MOBILE & WEARABLE DEVICES
Mobile and wearable disease diagnosis systems will be developed, and connection to a ubiquitous network may facilitate diagnosis at home.
MARKED POWER
Biochips are also expected to exhibit marked power for the selection of drugs and companion diagnostics, leading to safe and effective personalized medicine.
EARLY TREATMENT
Biochip development applying nano-/micro-technology and the diagnosis of diseases utilizing these were described herewith.
Combining with these, a way to develop new therapeutic methods can be found by applying these technologies. For example, the specific killing of cancer cells utilizing the optical characteristics of quantum dots is considered.